This inventor holds 5 USPTO granted patents, plus 2 CIPO patents. Top assignees: Gist-Brocades B.v., Gist-Brocades N.v., Dsm N.v.. Active years: 1994-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 64 
2 out of 236 
1 out of 475 
Years Active: 1994-2000
Title: The Innovations of Adrianus Wilhelmus Vollebregt
Introduction
Adrianus Wilhelmus Vollebregt is a notable inventor based in Naaldwijk, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the production of valuable compounds through innovative processes. With a total of 5 patents to his name, Vollebregt's work has had a lasting impact on the industry.
Latest Patents
Among his latest patents, Vollebregt has developed a process for the production of 7-ADCA via expandase activity. Additionally, he has worked on the cloning of the zymocin gene and its application in beverages. These innovations showcase his expertise in biotechnological advancements and their practical applications.
Career Highlights
Vollebregt has had a distinguished career, working with prominent companies such as Gist-Brocades N.V. and Gist-Brocades B.V. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development projects.
Collaborations
Throughout his career, Vollebregt has collaborated with esteemed colleagues, including Roelof Ary Bovenberg and Bertus Pieter Koekman. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.
Conclusion
Adrianus Wilhelmus Vollebregt's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire innovation in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile